שולי רווח נקי ממכירות Atea Pharmaceuticals, Inc. (AVIR)

סמל ולוגו של המותג Atea Pharma (AVIR)

Atea Pharmaceuticals (AVIR) aims for dominance in the antiviral segment through the execution of final clinical trials. The net profit margin trend on the GURU.Markets chart demonstrates the resilience of a non-cyclical business to macroeconomic shocks, where 0.00 serves as the final level marker. The stability of operational activities is further guaranteed by the humanitarian status of medicine and the absence of geopolitical risks.

AVIR: שיעור רווח נקי Atea Pharmaceuticals 04.07.2022 - 19.11.2026

Atea Pharmaceuticals Inc (AVIR) - פילוחי מדדים ודוחות פיננסיים

- שער מניה ותחזית מחירי מומחים:
ניתוח ראשוני של החברה:Atea Pharmaceuticals
סחורת הדגל של Atea Pharma

For Atea Pharmaceuticals (AVIR), which seeks to carve out a niche in the oral antiviral segment, the net profit margin serves as a key indicator of its effectiveness in capturing market share. This metric is calculated as the ratio of net income to total revenue, demonstrating the portion of funds remaining after covering all expenses, which allows investors to assess the actual profitability of the business model during a rapid asset screening.